Investigation of Newly Developed 1-piece Convex Baseplates in Subjects With Ileostomy

NCT ID: NCT01994876

Last Updated: 2014-04-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the performance and safety of two newly developed convex 1-piece ostomy appliances

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ileostomy - Stoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

First Coloplast Test 1

The subjects first test their own product to collect a baseline measurement

The subjects are randomised to first test Coloplast Test 1 and thereafter Coloplast Test 2

Group Type EXPERIMENTAL

Coloplast Test 1

Intervention Type DEVICE

Coloplast Test 1 is a newly developed 1-piece convex ostomy appliance

Coloplast Test 2

Intervention Type DEVICE

Coloplast Test 2 is a newly developed 1-piece convex ostomy appliance

First Coloplast Test 2

The subjects first test their own product to collect baseline measurements

The subjects are randomised to first test Coloplast Test 2 and thereafter Coloplast Test 1

Group Type EXPERIMENTAL

Coloplast Test 1

Intervention Type DEVICE

Coloplast Test 1 is a newly developed 1-piece convex ostomy appliance

Coloplast Test 2

Intervention Type DEVICE

Coloplast Test 2 is a newly developed 1-piece convex ostomy appliance

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coloplast Test 1

Coloplast Test 1 is a newly developed 1-piece convex ostomy appliance

Intervention Type DEVICE

Coloplast Test 2

Coloplast Test 2 is a newly developed 1-piece convex ostomy appliance

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Subjects must comply with the following criteria in order to participate in the investigation:

1. Are at least 18 years of age and have full legal capacity
2. Have had an ileostomy for at least 3 months
3. Have used a convex ostomy appliance for the last month
4. Have given written informed consent
5. Have an ileostomy with a diameter of 33 mm or less
6. Have experience leakage (seeping) under the baseplate at least two times over the last two weeks

Exclusion Criteria

Subjects complying with the following criteria must be excluded from participation in the clinical investigation:

1. Have a loop ostomy (also called double-barrel or ostomy with two outlets)
2. Are pregnant or breastfeeding
3. Currently receiving, or have received within the last 2 months, chemotherapy or radiation therapy.
4. Currently receiving or have received, within the last month, systemic or local steroid treatment (adreno-cortical hormone) in the peristomal area
5. Currently suffering from peristomal skin problems (i.e. bleeding or broken skin (weeping skin))
6. Are currently participating in another clinical investigation or has previously participated in this investigation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coloplast A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kalid S Abd-Elaziz, MD

Role: PRINCIPAL_INVESTIGATOR

QPS Holdings LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

QPS

Groningen, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP229

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.